Clindamycin hydrochloride (oral): Difference between revisions
Gerald Chi (talk | contribs) (Created page with "__NOTOC__") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CLINDAMYCIN HYDROCHLORIDE}} | |||
{{CMG}}; {{AE}} {{AK}} | |||
==Overview== | |||
Clindamycin (rINN) (IPA: [klɪndəˈmaɪsən]) is a lincosamide antibiotic used in the treatment of infections caused by susceptible microorganisms. Clindamycin is a semisynthetic antibiotic derived from lincomycin by 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the lincomycin. Clindamycin is marketed under various trade names including Dalacin (Pfizer), Cleocin (Pfizer), and in a foam as Evoclin (Connetics) and Duac(Stiefel). | |||
==Category== | |||
[[Lincosamides]] | |||
==US Brand Names== | |||
CLEOCIN HYDROCHLORIDE® | |||
==FDA Package Insert== | |||
''' [[Clindamycin hydrochloridedescription|Description]]''' | |||
'''| [[Clindamycin hydrochlorideclinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Clindamycin hydrochloridemicrobiology|Microbiology]]''' | |||
'''| [[Clindamycin hydrochlorideindications and usage|Indications and Usage]]''' | |||
'''| [[Clindamycin hydrochloridecontraindications|Contraindications]]''' | |||
'''| [[Clindamycin hydrochloridewarnings|Warnings]]''' | |||
'''| [[Clindamycin hydrochlorideprecautions|Precautions]]''' | |||
'''| [[Clindamycin hydrochlorideadverse reactions|Adverse Reactions]]''' | |||
'''| [[Clindamycin hydrochlorideoverdosage|Overdosage]]''' | |||
'''| [[Clindamycin hydrochlorideclinical studies|Clinical Studies]]''' | |||
'''| [[Clindamycin hydrochloridedosage and administration|Dosage and Administration]]''' | |||
'''| [[Clindamycin hydrochloridecompatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | |||
'''| [[Clindamycin hydrochloridedirections for use|Directions For Use]]''' | |||
'''| [[Clindamycin hydrochloridehow supplied|How Supplied]]''' | |||
'''| [[Clindamycin hydrochloridelabels and packages|Labels and Packages]]''' | |||
==References== | |||
{{Reflist|2}} | |||
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50162s082,50441s045,50639s013lbl.pdf | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 16:35, 9 January 2014
| Clindamycin hydrochloride |
|---|
| CLEOCIN HYDROCHLORIDE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overview
Clindamycin (rINN) (IPA: [klɪndəˈmaɪsən]) is a lincosamide antibiotic used in the treatment of infections caused by susceptible microorganisms. Clindamycin is a semisynthetic antibiotic derived from lincomycin by 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the lincomycin. Clindamycin is marketed under various trade names including Dalacin (Pfizer), Cleocin (Pfizer), and in a foam as Evoclin (Connetics) and Duac(Stiefel).
Category
US Brand Names
CLEOCIN HYDROCHLORIDE®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50162s082,50441s045,50639s013lbl.pdf